SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950144-04-012012
Filing Date
2004-12-13
Accepted
2004-12-13 15:00:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 KV PHARMACEUTICAL COMPANY / EARNEST PARTNERS LLC g92349fsc13g.htm SC 13G 26091
  Complete submission text file 0000950144-04-012012.txt   28089
Mailing Address 2503 S HANLEY RD ST LOUIS MO 63144
Business Address 2503 S HANLEY RD ST LOUIS MO 63144 3146456600
KV PHARMACEUTICAL CO /DE/ (Subject) CIK: 0000057055 (see all company filings)

IRS No.: 430618919 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SC 13G | Act: 34 | File No.: 005-12338 | Film No.: 041198557
SIC: 2834 Pharmaceutical Preparations

Mailing Address 75 FOURTEENTH STREET, SUITE 2300 ATLANTA GA 30309
Business Address 75 FOURTEENTH STREET, SUITE 2300 ATLANTA GA 30309 4048158772
EARNEST PARTNERS LLC (Filed by) CIK: 0001102578 (see all company filings)

IRS No.: 582386669 | State of Incorp.: GA | Fiscal Year End: 1231